The TBM programme targets a particular niche within biomedical research: advanced (“late stage”) application-driven biomedical research with a marked societal applicability, yet with only limited potential for industrial applicability.
A TBM project needs to satisfy each of the following conditions:
- It is aimed at the development of a new therapy, diagnosis and/or specific prevention of a particular human disease or a comparison of existing procedures in order to find out their relative efficacy and cost-effectiveness.
- It is directed at research that is positioned late in the path from discovery to a specific application (i.e. there is a clinically relevant proof-of-concept) and aims at translating and developing scientific findings into clinical applications rather than creating new knowledge from scratch. On the other hand, it is not positioned too late in the path from discovery to application: it does not consist of implementation activities that no longer require any research.
- It offers a clear applicability with an added value for the Flemish health situation, including at least a positive medical impact for a particular group of patients or a cost reduction for the Flemish healthcare system.
- At the time of submitting the application (or in the near future), the industry is not interested in your project for commercial reasons.
A TBM project will last a minimum of 2 years and a maximum of 4 years. The project budget must range between €250,000 and €1,000,000 (for large or multicentric trials, exceptionally budgets up to € 1,500,000 euro are allowed).
Any Flemish research centre can submit a TBM project. A consortium of applicants (with one main applicant and one or more co-applicants) or a single (main) applicant can submit an application. Given the clinical focus of the programme, however, at least one Flemish hospital must be included in the consortium. In addition, the aggregated share of Flemish hospitals in the consortium must amount to at least 10% of the total project costs. Non-Flemish research centres can also be included in the consortium as co-applicants. A condition is, however, that the total budget for non-Flemish research centres does not exceed 20% of the total budget. Companies can not act as applicants. Companies are only allowed to act in the capacity of subcontractor. The cumulated contribution of subcontractors must, however, remain below 30% of the total budget.
There is one deadline each year (April).
The Research Coordination office:
- Helps with process-related questions (e.g. questions about the application template, submission procedure etc.).
- Acts as an intermediary between the researchers and FWO
- Acts as an intermediary when internal (TTO, PER, FIN) or external (ICL, etc.) consultation is necessary
- Helps with preparing the project budget
- Checks the final project budget
- Helps with administrative formalities relating to Hasselt University
- Coordinates the signing process of the declaration of intent by the rector